Home > Annual Financials > PARNAX LAB

PARNAX LAB Financial Statement Analysis
[BOM: 506128]

The Revenues of PARNAX LAB have increased by 12.59% YoY .
The Earnings Per Share (EPS) of PARNAX LAB has increased by 19.83 % YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

PARNAX LAB Last 5 Annual Financial Results
[BOM: 506128]

ConsolidatedMar2025
Mar2024
Mar2023
Mar2022
Mar2021
Revenues ₹189 Cr₹168 Cr₹16,303 Cr₹90 Cr₹95 Cr
Expenses ₹165 Cr₹145 Cr₹14,000 Cr₹80 Cr₹89 Cr
Operating Profit (Excl OI) ₹24 Cr₹23 Cr₹2,303 Cr₹9.95 Cr₹6.43 Cr
Other Income ₹0.82 Cr₹0.77 Cr₹33 Cr₹0.21 Cr₹0.67 Cr
Interest ₹5.35 Cr₹4.95 Cr₹523 Cr₹5.08 Cr₹4.60 Cr
Depreciation ₹6.96 Cr₹6.53 Cr₹587 Cr₹5.16 Cr₹4.46 Cr
Profit Before Tax ₹12 Cr₹12 Cr₹1,226 Cr₹-0.08 Cr₹-1.97 Cr
Profit After Tax ₹9.63 Cr₹8.63 Cr₹826 Cr₹-0.36 Cr₹-2.92 Cr
Consolidated Net Profit ₹9.61 Cr₹8.62 Cr₹824 Cr₹-0.36 Cr₹-2.91 Cr
Earnings Per Share (Rs)₹10.03₹8.37₹7.50₹8.40₹-0.43
PAT Margin (%)6.155.105.155.07-0.40
ROE(%)14.9214.3915.9120.93-1.11
ROCE(%)14.7113.6115.2017.345.83
Total Debt/Equity(x)0.730.990.821.411.71

Key Financials

Market Cap : ₹ 129.0 Cr
Revenue (TTM) : ₹ 205.2 Cr
Net Profit(TTM) : ₹ 11.0 Cr
EPS (TTM) : ₹ 9.6
P/E (TTM) : 11.7

Industry Peers & Returns1W1M1Y
PARNAX LAB -8.8% -12.1% -31.6%
SUN PHARMACEUTICAL INDUSTRIES -0.2% 7.1% 1.1%
DIVIS LABORATORIES 0.8% -6% 4.2%
CIPLA -0.2% 1.4% -0.9%
TORRENT PHARMACEUTICALS 1.2% 6.4% 13.1%
DR REDDYS LABORATORIES 1.2% 5.8% 4.2%
MANKIND PHARMA -1.1% -4.5% -13.7%
ZYDUS LIFESCIENCES -0.5% -0.5% -4.8%
LUPIN 0.5% 7.2% 0.5%


PARNAX LAB Revenues
[BOM: 506128]

Y-o-Y

12.59 %

5 Yr CAGR

18.62 %

Years Revenues % Change
Mar2025 ₹189 Cr
12.59
Mar2024 ₹168 Cr
-98.97
Mar2023 ₹16,303 Cr
18,002.56
Mar2022 ₹90 Cr
-5.51
Mar2021 ₹95 Cr -


PARNAX LAB Operating Profit
[BOM: 506128]

Y-o-Y

2.42 %

5 Yr CAGR

38.35 %

Years Operating Profit % Change
Mar2025 ₹24 Cr
2.42
Mar2024 ₹23 Cr
-99.00
Mar2023 ₹2,303 Cr
23,053.01
Mar2022 ₹9.95 Cr
54.77
Mar2021 ₹6.43 Cr -

Operating Margins
Y-o-Y

-9.04 %

5 Yr CAGR

16.65 %

Years Operating Margin% % Change
Mar2025 12.48%
-9.04
Mar2024 13.72%
-2.90
Mar2023 14.13%
27.99
Mar2022 11.04%
63.80
Mar2021 6.74% -

PARNAX LAB Profit After Tax
[BOM: 506128]

Y-o-Y

11.50 %

5 Yr CAGR

Positive

Years Profit After Tax % Change
Mar2025 ₹9.61 Cr
11.50
Mar2024 ₹8.62 Cr
-98.95
Mar2023 ₹824 Cr
Positive
Mar2022 ₹-0.36 Cr
Negative
Mar2021 ₹-2.91 Cr -

PAT Margins
Y-o-Y

20.59 %

5 Yr CAGR

Positive

Years PAT Margin(%) % Change
Mar2025 6.15 %
20.59
Mar2024 5.1 %
-0.97
Mar2023 5.15 %
1.58
Mar2022 5.07 %
Positive
Mar2021 -0.4 % -

PARNAX LAB Earnings Per Share (EPS)
[BOM: 506128]

Y-o-Y

19.83 %

5 Yr CAGR

Positive

Years EPS % Change
Mar2025 ₹10
19.83
Mar2024 ₹8.37
11.60
Mar2023 ₹7.50
-10.71
Mar2022 ₹8.40
Positive
Mar2021 ₹-0.43 -

PARNAX LAB Return on Capital Employed (ROCE)
[BOM: 506128]

Y-o-Y

8.08 %

5 Yr CAGR

26.03 %

Years ROCE % Change
Mar2025 14.71%
8.08
Mar2024 13.61%
-10.46
Mar2023 15.2%
-12.34
Mar2022 17.34%
197.43
Mar2021 5.83% -

PARNAX LAB Share Price vs Sensex

Current Share Price : ₹112.2
Current MarketCap: ₹ 129.0 Cr
Updated EOD on :Dec 05,2025

Share Price Returns(%) 1 Week 1 Month 1 Year
PARNAX LAB

-8.8%

-12.1%

-31.6%

SENSEX

0%

2.7%

6.8%

PARNAX LAB related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about PARNAX LAB Financials


How the annual revenues of PARNAX LAB have changed ?

The Revenues of PARNAX LAB have increased by 12.59% YoY .

How the Earnings per Share (EPS) of PARNAX LAB have changed?

The Earnings Per Share (EPS) of PARNAX LAB has increased by 19.83 % YoY .